• J&J raises sales forecast on strong demand for cancer drugs

    6 monthes ago - By Reuters

    Johnson & Johnson reported a better-than-expected first-quarter profit on Tuesday and raised its full-year sales forecast, helped by strong demand for its cancer treatments.
    Read more ...

     

  • Goldman profit up 27 percent as trading surges

    6 monthes ago - By Reuters

    Goldman Sachs Group Inc reported a 27 percent rise in quarterly profit on Tuesday, driven by a surge in trading revenue due to increased market volatility.
    Read more ...

     

  • Futures rise on strong earnings from Netflix, health majors

    6 monthes ago - By Reuters

    U.S. stock index futures rose on Tuesday as strong earnings from Netflix, Johnson & Johnson and UnitedHealth boosted optimism over what is expected to be the strongest earnings season in seven years.
    Read more ...

     

  • J&J quarterly profit beats on demand for cancer drugs

    6 monthes ago - By Reuters

    Johnson & Johnson reported a better-than-expected first-quarter profit on Tuesday and raised its full-year sales forecast, helped by growing demand for its cancer drugs.
    Read more ...

     

  • Johnson & Johnson tops profit and revenue expectations in 1Q

    6 monthes ago - By Chron

    NEW BRUNSWICK, N.J. - Johnson & Johnson is reporting better than expected profit and revenue for the first quarter
    The New Brunswick, New Jersey, company on Tuesday reported profits of $4.37 billion, or $1.60 per share. Adjusted per-share earnings were $2.06, a nickel better than expected, according to a poll by Zacks Investment Research.
    The world's biggest maker of health care products posted revenue of $20.01 billion, topping analyst projections for $19.48 billion.
    Johnson & Johnson expects full-year earnings in the range of $8 to $8.20 per share, with revenue in the range of $81...
    Read more ...